Graham Robinson, a prominent biotech and technology lawyer, is leaving Skadden Arps for Kirkland & Ellis, highlighting ongoing talent competition among top law firms despite a downturn in dealmaking. Robinson, who has been a key player in major biotech transactions, will join Kirkland with other senior partners, potentially earning $20 million annually. His departure follows a trend at Skadden, which has seen several top lawyers leave for rivals while still leading in public company M&A deals.
